Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

Outcome of Haploidentical Peripheral Blood Allografts Using Post-Transplantation Cyclophosphamide Compared to Matched Sibling and Unrelated Donor Bone Marrow Allografts in Pediatric Patients with Hematologic Malignancies: A Single-Center AnalysisAllogeneic hematopoietic stem cell transplantation (allo-HSCT) can be a curative option for patients with malignant, hematologic, and immune disorders….

Read the full article here

Source: www.astctjournal.org

Categories: Hem/Onc News and Journals, Latest Headlines

Tags: WomensHistoryMonth

Tweets with this article

ASTCT

As a part of #WomensHistoryMonth, Transplantation and Cellular Therapy is pleased to highlight recent articles published by our female Associate Editors and Editorial Board Members. These articles are available for free until April 1st. @ASTCT_Journal https://t.co/JnZllZI8gA https://t.co/8FAvFIlllM

ASTCT Learning Center: 2024 ASTCT Advanced Practice Provider Onboarding Guide

Introduction: Advanced Practice Providers (APPs) play a crucial role in the functioning of transplant and cellular therapy programs of all sizes. Physician Assistant and Nurse…

ASTCT April 24, 2024

ASTCT Learning Center: 2023 Updated Late Effects Guidelines Webinar

The number of long-term survivors of hematopoietic cell transplantation (HCT) and cellular therapy is rapidly expanding. Guidelines for the screening and preventative practices for HCT…

ASTCT April 23, 2024

Early inflammatory markers as prognostic indicators following allogeneic stem cell transplantation

Researchers at the University of Birmingham in the UK have explored the dynamics of inflammatory biomarkers following allogeneic hematopoietic stem cell transplantation. This study seeks…

ASTCT April 21, 2024

ASTCT Learning Center: ASTCT Practice Guidelines “Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy (Revision)”

Program Description: Articles designated for CME credit are designed to be the next step in the process of translating clinically relevant, evidence-based recommendations into clinical…

ASTCT April 20, 2024

Reduced Cytokine Release Syndrome and Improved Outcomes with Earlier Immunosuppressive Therapy in Haploidentical Stem Cell Transplantation

Classically, the optimal donors for patients requiring hematopoietic stem cell transplantation (HSCT) have been HLA-matched relatives or unrelated donors in the National Marrow Donor Program…

Chimeric Antigen Receptor T-Cell (CAR-T) April 19, 2024

ASTCT Learning Center: 2023 Updated Late Effects Guidelines Webinar

The number of long-term survivors of hematopoietic cell transplantation (HCT) and cellular therapy is rapidly expanding. Guidelines for the screening and preventative practices for HCT…

ASTCT April 18, 2024

FY 2025 Hospital Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital Prospective Payment System (LTCH PPS) Proposed Rule – CMS-1808-P Fact Sheet | CMS

On April 10, 2024, the Centers for Medicare & Medicaid Services (CMS) issued the fiscal year (FY) 2025 Medicare hospital inpatient prospective payment system (IPPS)…

ASTCT April 17, 2024

ASTCT Learning Center: Palliative and Supportive Care Needs of Patients Undergoing HSCT and Adoptive Cellular Therapy

This webinar is the first in a series of three presented by the ASTCT Palliative Care SIG. The speakers will share their insight as to…

ASTCT April 16, 2024

ASTCT > Attend > Joint ASTCT-EBMT Basic and Translational Scientific Meeting

The American Society for Transplantation and Cellular Therapy is an international professional membership association of more than 3,600 physicians, investigators and other health care professionals…

ASTCT April 15, 2024

ASTCT Committee on Practice Guidelines Survey on Evaluation & Management of Relapsed Refractory Multiple Myeloma after Failure of Chimeric Antigen Receptor T-Cell Therapy

Chimeric antigen receptor T-cell therapy (CAR-T) has revolutionized the management of relapsed and/or refractory multiple myeloma (RRMM). However, CAR-T treatment failure is not uncommon and…

Rahul Banerjee, MD April 15, 2024

Related Articles